Source: European Parliament
Question for written answer E-000373/2025
to the Commission
Rule 144
Gerald Hauser (PfE)
It is scientifically documented that the risk of contracting COVID-19 increases with the number of vaccinations administered. Under Directive 2001/83/EC, all suspected adverse reactions to medicinal products should be reported to the competent national authorities. These notifications are examined, and subsequently forwarded to the European Medicines Agency (EMA) and published. However, so far, only around 6 % of all side effects of COVID-19 vaccinations have been reported. Nevertheless, more than two million cases of vaccine damage have already been documented. A further problem with COVID-19 vaccinations is that countless millions of infections after an ineffective vaccination – known as breakthrough cases – have gone largely unreported. Most of these cases of vaccination damage were wrongly declared as ‘long Covid’. This is mainly due to the fact that the accounting regarding medical services in the Member States is regulated accordingly and that, in the vast majority of cases, previous vaccinations are not taken into account at all.
- 1.What measures does the Commission plan to take to ensure that all COVID-19 vaccine side effects and breakthrough cases in the EU are reported and documented?
- 2.How does the Commission guarantee that damage caused by COVID-19 Vaccine breakthrough cases will in future be correctly documented as vaccine side-effects and not erroneously as ‘long Covid’?
- 3.When will the Commission withdraw the COVID-19 vaccinations from the market, since it has been demonstrably proven that they are harmful and ineffective under the terms of Directive 2001/83/EC?
Submitted: 28.1.2025